Related Experiment Videos
Urachal signet-ring cell carcinoma.
K T Chen1, R D Workman, G Rainwater
1Department of Pathology, Fresno Community Hospital and Medical Center, California.
Urology
|October 1, 1990
Summary
Urachal signet-ring cell carcinoma is an aggressive cancer. This rare tumor has a poor prognosis, with a low five-year survival rate and limited disease-free survival observed in reported cases.
Area of Science:
- Urologic oncology
- Pathology
- Surgical oncology
Background:
- Urachal carcinoma is a rare malignancy arising from the urachus, a remnant of the allantois.
- Signet-ring cell carcinoma is a rare histological subtype with distinct clinical behavior.
Observation:
- This report details a case of urachal signet-ring cell carcinoma.
- The case is compared with 18 previously documented instances of this rare cancer.
Findings:
- Urachal signet-ring cell carcinoma demonstrates aggressive behavior.
- The overall five-year survival rate is reported as 27 percent.
- A five-year disease-free survival was achieved in only one patient.
Implications:
- Early diagnosis and aggressive treatment strategies are crucial for improving outcomes.
- Further research is needed to understand the specific biology and optimal management of this rare entity.
- This case contributes to the limited body of literature on urachal signet-ring cell carcinoma, aiding future clinical decision-making.